Skip to main content
. 2023 Nov 30;41(49):7435–7443. doi: 10.1016/j.vaccine.2023.11.008

Table 1.

Study countries, characteristics and sample sizes.

Ethiopia Guyana Rwanda Senegal Sri Lanka Uganda
Country characteristics
 Month and year of nationwide HPV vaccine introduction December 2018 January 2017 April 2011 October 2018 September 2017 October 2015
 WHO region AFRO PAHO AFRO AFRO SEARO AFRO
 HPV vaccine delivery strategy based on WHO classification [13] School-based School-based School-based Facility-based Mixed School-based
 Gender and target age group for HPV vaccination (2019) 14-year-old girls 10-year-old girls and boys 12-year-old girls (grade 6) 9-year-old girls 10-year-old girls (grade 6) 10-year-old girls
 Number of doses in the HPV vaccine schedule (2019) 2 doses 2 doses 2 doses 2 doses 2 doses 2 doses
 HPV vaccine interval between doses (2019) 6 months 6 months 6 months 6 months 6 months 6 months
 Reported national target population size for HPV vaccination (2019) 1,284,036 15,000 149,111 204,235 173,130 681,758
 National coverage for HPV vaccine last dose, official coverage (2019) [14] 94 % 55 % females; 62 % males 97 % 27 % 99 % 65 %
Sample sizes
 Health facilities 60 43 42 56 30 66
 District administrative offices 17 n/a 11 14 10 21
 Zones or sub-cities administrative offices 9 n/a n/a n/a n/a n/a
 Regional administrative offices 3 5 n/a 7 n/a n/a
 National administrative office 1 1 1 1 1 1

Abbreviations: AFRO: Africa region of the World Health Organization; HPV: human papillomavirus; PAHO: Pan American Health Organization; Americas region of the World Health Organization; SEARO: South-East Asia region of the World Health Organization; WHO: World Health Organization.

Note: Fields indicated not applicable (n/a) when the administrative level is not included in the country or does not have a role in immunization program activities. In Guyana, two administrative offices were interviewed in one region, resulting in five observations at the subnational level in four regions.